Home Blog Page 203

Aperture Partners With the AltaSeads Conservancy to Support Health of American Pacific Coastline

By
NT Editor
-
0
Aperture Partners With the AltaSeads Conservancy to Support Health of American Pacific Coastline

GOLDEN VALLEY, Minn., October 10, 2023 (Newswire.com) - Aperture Pet & Life, the integrated company for some of the largest brands in aquatics, including Bulk Reef Supply, Neptune Systems, EcoTech Marine and Aquaillumination, is proud to announce a collaboration with the AltaSeads Conservancy non-profit organization. 

AltaSeads Conservancy is a non-profit organization working to ensure the health and biodiversity of wild macroalgae ecosystems in the nearshore coastal zones of the American Pacific. Through scientific principles, technology, and resources for sustainable restoration and management of macroalgal beds and kelp forests, Altaseads is hoping to play a critical role in the fight against climate change and ocean pollution. Kelp forests support economically and ecologically important species of fish, mammals, and invertebrates by serving as feeding and breeding grounds.

In addition to maintaining seed banks of giant kelp (Macrocystis pyrifera), bull kelp (Nereocystis luetkeana), golden kombu (Laminaria farlowii) and ribbon kelp (Alaria marginata), AltaSeads is starting an initiative to restore, breed, farm and provide education related to the maintenance of natural and farmed kelp as part of the blue economy initiative. Located within the AltaSea at the Port of Los Angeles campus, and arising from $11 million of Arpa-E, NOAA, Sea Grant, and WWF-funded research, this organization is well en route to lead kelp conservation efforts.

Aperture is providing an equipment donation to ensure AltaSeads has the most innovative technology on its mission. Aperture is also amplifying AltaSeads' work to create more awareness to the aquatics community.

“The fully programmable Radion G6 Pros by EcoTech Marine are supplying our tanks with ideal PAR and spectrum for growing kelp. And the AI Blade Refugium is giving a reliable source of red spectrum to our seedbank strains, all while the Neptune Systems Apex is monitoring the water parameters. This equipment is an incredible help to ensure our aquaculture systems run smoothly and efficiently for all of our kelp biomass bulking efforts for restoration, sporophyll induction or looking for specific traits on kelp sporophytes,” said Michael Marty-Rivera of AltaSeads. “We are very excited by this partnership, as we are building up an organization to be a reliable source for stakeholders in the world of kelp.”

Aperture Circle has partnered with organizations who are passionate about conserving the planet's most fragile ecosystems and is pleased to be able to assist work ensuring the survival of coastal macroalgae, also known as “the reefs of the West Coast.”

"We're excited to be able to contribute to the work of AltaSeads," said Jay Sperandio, Vice President of Marketing at Aperture. "By supporting them by sharing their work with our passionate customers and supplying them with EcoTech, Neptune and Aquaillumination technology needed for their kelp farm and gene bank, we hope to further advance how the aquatics industry can bring support to worldwide conservation efforts and be part of the solution." 

Aperture

Aperture is a leading online retailer, manufacturer and distributor of products in over 50 countries through an online marketplace for saltwater aquarists, world-class products for the success of saltwater, freshwater and reptile and amphibian ecosystems and one of the pet industry’s largest YouTube platforms, with over 400,000 subscribers and 130 million views. Through Bulk Reef Supply, Neptune Systems, EcoTech Marine, Aquaillumination, Leap Habitats and others, Aperture offers products and resources needed to create thriving ecosystems. www.apetlife.com

AltaSeads Conservancy

AltaSeads Conservancy is a tax-exempt 501(c)(3) non-profit organization with the mission to ensure the health and biodiversity of wild macroalgae ecosystems in the nearshore coastal zones of the American Pacific. https://www.altaseadsconservancy.org 

Contact Information:
Jay Sperandio
Vice President, Marketing
[email protected]


Original Source: Aperture Partners With the AltaSeads Conservancy to Support Health of American Pacific Coastline

Dr. Andrew Fanous, MD FAANS, Joins NuEyes Board of Directors as Chief Medical Officer

By
NT Editor
-
0
Dr. Andrew Fanous, MD FAANS, Joins NuEyes Board of Directors as Chief Medical Officer

NEWPORT BEACH, Calif., October 10, 2023 (Newswire.com) - – NuEyes, a leading innovator in augmented reality (AR) smart glasses technology, is pleased to announce the appointment of Dr. Andrew Fanous, MD FAANS, to its Board of Directors and as the company's Chief Medical Officer. Dr. Fanous brings a wealth of experience and expertise in the fields of neurosurgery and medical technology, making him a valuable addition to NuEyes as it continues to push the boundaries of smart glasses technology specific to the medical and dental industries.

Dr. Fanous, a highly regarded neurosurgeon, is widely recognized for his significant contributions to the medical field. He has played an instrumental role in advancing the treatment of neurological disorders and has a deep understanding of the potential applications of augmented reality in healthcare. In his role as Chief Medical Officer, Dr. Fanous will provide strategic guidance and medical expertise to help shape the future of NuEyes' cutting-edge technology.

"I am excited to join NuEyes’ board of directors, a company that is clearly at the forefront of developing transformative augmented reality solutions," said Dr. Fanous. "I believe that augmented reality smart glasses have the potential to significantly improve the lives of clinicians in the surgical and dental fields. I am thrilled to be working alongside the talented team at NuEyes in order to advance this technology and bring it to a broader audience."

NuEyes' smart glasses, “NuLoupes,” will bring surgical and dental loupes into the 21st century with its revolutionary technology and ecosystem for medical professionals. Moving from traditionally fixed magnification to the NuLoupes high-resolution variable digital magnification will provide surgeons and dentists with more versatility and viewing area. Using NuEyes’ proprietary patent-pending camera system, NuLoupes is able to provide live 3D stereoscopic imaging with near-zero latency. The camera system delivers sub-millimeter accurate depth perception that allows physicians to accurately visualize the surgical environment. This revolutionary technology is key to providing natural viewing with enhanced magnification of detailed information in front of the users.

"Dr. Fanous' appointment to our Board of Directors and as Chief Medical Officer is a testament to NuEyes' commitment to excellence in both medical technology and patient care," said Mark Greget, CEO and co-founder of NuEyes. "His deep expertise in neurosurgery and his passion for innovation align perfectly with our mission to empower medical professionals with cutting-edge smart glasses technology." 

As NuEyes continues to expand its presence into the medical market, Dr. Fanous' leadership and medical insights will play a pivotal role in driving innovation and ensuring that the company remains at the forefront of smart glasses technology within both the medical and dental industries.

ABOUT NUEYES TECHNOLOGIES, INC.

NuEyes is a veteran-owned smart glass technology company based in Orange County, California. It was launched in January 2016 to assist those with eye conditions such as macular degeneration, glaucoma, and retinitis pigmentosa. Over the past five years, NuEyes has seen extensive sales growth and has obtained federal, state, and insurance reimbursement for its devices. NuEyes addresses a multitude of augmented-reality markets including the accessibility, medical, and dental industries.

Contact Information:
Regina Chatman
Director, Sales and Marketing
[email protected]
800-605-4033
Related Images


Original Source: Dr. Andrew Fanous, MD FAANS, Joins NuEyes Board of Directors as Chief Medical Officer

On World Mental Health Day, BHG Financial Teams Up with the Kevin Love Fund to Expand Their Free SEL Curriculum to Florida Schools

By
NT Editor
-
0
On World Mental Health Day, BHG Financial Teams Up with the Kevin Love Fund to Expand Their Free SEL Curriculum to Florida Schools

DAVIE, Fla., October 10, 2023 (Newswire.com) - The theme of this year’s World Mental Health Day is "Mental health is a universal right." With that in mind, BHG Financial (BHG) has taken the first steps into building a relationship with the Kevin Love Fund (KLF), beginning with a $25,000 donation to the mental health foundation.

The Kevin Love Fund was formed by five-time NBA all-star and current professional basketball player, Kevin Love, in 2018. The non-profit organization is dedicated to breaking the stigma around mental health and ensuring people have the emotional and physical support they need.

“Mental health isn’t just an athlete thing. What you do for a living doesn’t have to define who you are. This is an everyone thing,” stated Love.

After hearing Kevin’s story about his own courage to bring awareness to this topic, BHG leadership was inspired to reach out. The similarities between the professional sports world and the business world and the importance of mental health are predominantly what drew BHG to the cause.

"Achieving business success is very similar to sports success. The pressure is heavy, the stakes are extremely high, and the stress can wreak havoc on a person's mental health," says Al Crawford, co-founder. “As a driven and competitive company, we want to make sure our employees are taken care of – a healthy team is needed in any industry.”

BHG has always believed that the health of its people determines the health of the organization, designating specific teams to help build programs and benefits that ensure their employees have the support they need. These include “Wellness Weekends,” free counseling sessions, 100% coverage of health insurance premiums, and more.

"We wanted to ensure that our people had both the outlets and information they need to feel supported, and we wanted to somehow extend that care to our communities," said Tyler Crawford, COO. "The Kevin Love Fund is a perfect fit."

BHG and the Kevin Love Fund executives are currently exploring how they can work together in the future to achieve that goal of community outreach, including co-sponsoring an event for Mental Health Awareness Month in May, and expanding KLF’s free SEL curriculum to Florida schools. Both organizations seek to improve knowledge, raise awareness, and drive actions that promote and protect everyone’s mental health as a universal human right.

About BHG Financial

BHG Financial (BHG) is a national leader in providing innovative financial solutions to professionals, small business owners, and consumers via their lending division, BHG Money. Since 2001, BHG has provided $16.4 billion in loan solutions, helping clients achieve greater financial flexibility in their businesses and personal lives. With streamlined, affordable financing that offers a concierge, full-service approach to lending, and some of the most accommodating terms on the market, BHG Financial supports clients in any phase of their financial journey.

BHG also provides high-quality assets to small- to mid-sized banks via the BHG Financial Institutional Network. One of the largest bank networks in the country, it has over 1,600 members. The network supports financial institutions nationwide by helping with asset growth via access to BHG's top-performing loans through its state-of-the-art loan delivery platform and by offering premium regulatory services.

BHG Financial is partially owned by Pinnacle Bank (PNFP) and has headquarters in Fort Lauderdale, FL, and Syracuse, NY. To represent the company's growth and dedication to continuously expanding its services, Bankers Healthcare Group became BHG Financial in 2021. For more information, visit https://bhgfinancial.com/.

Contact Information:
Meredith Crawford
SVP, Corporate Communications
[email protected]


Original Source: On World Mental Health Day, BHG Financial Teams Up with the Kevin Love Fund to Expand Their Free SEL Curriculum to Florida Schools

The Greatest Horror Movies of 1980: 80s Horror Movie Memories

By
NT Editor
-
0
The Greatest Horror Movies of 1980: 80s Horror Movie Memories

We take a look back at the greatest horror movies of 1980 in this feature-length edition of 80s Horror Memories.

With the death of disco in 1979 and a demand for change, the 1980s evolved into a neon-soaked, totally rad decade held firm together with cans of “Aqua Net” burning a hole in the ozone. The time for free love and hope for peace was over. It was time for a revolution. But with filmmakers, their creative freedoms would lead to exploring more areas which haven’t been touched on before. It was the year horror would forever be changed.  

In this special episode of 80s Horror Memories, we take a feature-length look at the year 1980 as a whole, taking deep dives into the influential horror flicks of the year. Here are the movies we profile:

Dressed to Kill: Brian DePalma’s controversial slasher, which, if anything, is even more provocative in 2023 than it was in 1980.

Maniac: William Lustig’s grimy thriller starring 80s horror icon Joe Spinell. 

Alligator: Originally conceived as a Jaws knockoff, this horror comedy features a charming lead performance by the late Robert Forster. 

Friday the 13th: The slasher movie that started it all and pushed the envelope regarding mainstream horror violence. 

The Shining: Stanley Kubrick’s classic is considered one of the greatest horror movies of all time, but is despised by Stephen King himself. Why?

Prom Night: A classic piece of Canuxsploitation, Prom Night is probably Jamie Lee Curtis’s best slasher outside of the Halloween series.

The Fog: John Carpenter’s follow-up to Halloween was a box office disappointment in 1980 but is now considered a classic. 

We discuss all of these classics with our special guests, Craig Perry (Final Destination), Doug Jones (Hellboy), Eric Red (The Hitcher), Patrick Lussier (Scream), and Sandy King (They Live).

What’s your favorite 1980 horror movie? Let us know in the comments! And check out all episodes of 80s Horror Memories HERE.

Originally published at https://www.joblo.com/the-greatest-horror-movies-of-1980-80s-horror-movie-memories/

Weekend Box Office: The Exorcist: Believer opens with a soft $27.2 Million

By
NT Editor
-
0
Weekend Box Office: The Exorcist: Believer opens with a soft .2 Million

Despite some genuinely horrible reviews from critics and fans alike, The Exorcist: Believer saw a franchise best debut of $28 million.

The Exorcist: Believer saw a first weekend take of $27.2 million, coming in under even the most modest of projections, including our own low end $30 million prediction, yet still having the best opening of the franchise. That number represents a near $10 million improvement over the last theatrically released Exorcist film: 2004’s Exorcist: The Beginning ($18 million). That’s the good news, the bad news is that even with a franchise best opening and a reported budget of just $30 million before advertising, this opening is still a fairly sizable disappointment for the studio.

This film has gotten some absolutely horrendous reviews, including a 4/10 from our own Chris Bumbray who called it “awful.” Those reviews mixed with its horrible 54% audience score means this one will likely sink in the coming weeks. That is not what Universal needs from this film as they reportedly shelled out $400 million to retain the rights to the Exorcist franchise with hopes that a new trilogy could cover those costs. Surely the studio and producer Jason Blum thought they could recreate the success of 2018’s Halloween which garnered fairly solid reviews that translated into a $76.2 million opening on its way to a $159.3 million domestic total and a $259.9 million worldwide take.

The "Body and the Blood" promo for The Exorcist: Believer shows a scene where a possessed girl goes to church

All eyes will be on how much of a tumble this one takes next week, but with horrible reviews, bad word of mouth and a highly anticipated movie coming to theaters next week (Taylor Swift: The Eras Tour which has broken a number of records already before even opening), you can expect this one to take a Halloween Ends level fall (that movie lost 80% of its audience in its second week). Perhaps this one will play better at home when it hits Peacock in 45 days as the day and date releases of Halloween Kills/Ends were big hits for the streamer.

Spots two through five go to Paw Patrol: The Mighty Movie which lost 48% of its audience with a $11.7 million second week while Saw X benefitted from its stellar reviews (the best reviewed movie in the entire franchise) and saw just a 55% drop in its audience for a second week take of $8.1 million. Films like these tend to have second week drops in the 60% range, so this is a better than expected hold for the Tobin Bell fronted film. Coming in fourth place with a 56% drop in its second week is The Creator with just $6.1 million. As we said last week, despite many audience members not finding this particular piece of IP to be a modern sci fi classic, studios should not be dissuaded from taking on original ideas in the future. I enjoy a comic book film as much as the next person, but nothing can ever top the first time I saw The Matrix in theaters and was absolutely blown away by something I had never ever experienced before. Experiences like that can go away if all we get are sequels and remakes. Coming in fifth place with $3.1 million is the The Blind which follows the faith based story of Duck Dynasty patriarch Phil Robertson.

Spots six through nine go to your holdover titles such as A Haunting in Venice with $2.7 million followed by The Nun II which took a larger than expected tumble this week with $2.5 million, likely due to the addition of The Exorcist: Believer targeting a similar audience. Eighth place goes to Dumb Money which actually saw a decent hold, only losing 35% of its audience for a $2.1 million weekend. I can not sing the praises of this film enough and wish more people would have made it out to theaters to see it, but hopefully those who didn’t think a trip to their local multiplex was worth it for this stock market based film will make the time when it eventually hits home video. Ninth place goes to the Denzel Washington trilogy capper The Equalizer 3 with an additional $1.8 million. Rounding out the top ten is the 30th anniversary re-release of Hocus Pocus with an estimated weekend take of $1.5 million added to its lifetime gross of over $46 million.

Hocus Pocus 2, streaming ratings

Outside of the top ten but earning a respectable 31.5 thousand per screen average for a weekend take of $220,800 is the Larry Charles directed Dicks: The Musical.

What do you make of The Exorcist: Believer’s opening? Do you think it will have a massive drop next week? Let us know in the comments and don’t forget to check out our weekly poll where we ask What is your favorite horror film released in the past 2 years?

Originally published at https://www.joblo.com/weekend-box-office-the-exorcist-believer-opens-with-soft-27-2-million/

David Gordon Green may not direct remaining Exorcist films

By
NT Editor
-
0
David Gordon Green may not direct remaining Exorcist films

David Gordon Green may sit out of directing the remainder of The Exorcist trilogy, as other projects may catch his attention.

Even as The Exorcist: Believer gets panned by critics and looks to be one of the craziest gambles ever by a movie studio – Universal shelled out $400 million for the rights – director David Gordon Green may avoid helming the rest of the planned trilogy. But his decision may have less to do with its reception than just how he operates.

Speaking with The Hollywood Reporter, David Gordon Green said it’s quite possible that he’ll get sucked into another project instead of directing more Exorcist movies. “My intention is just to start making things, and as those plans come together, if I find myself in that [The Exorcist: Deceiver] director’s chair, I’d be thrilled… But right now, I’m navigating it from a story perspective and looking at my realities of life as I pivot.” He added, “One of the things that’s been really great between these horror franchises is doing that comedy series on HBO, The Righteous Gemstones. So it’s fun to be able to step away, take a deep breath, have a big laugh, and then get back to work in the genre.”

Even though he directed all three films in the recent Halloween trilogy – which got progressively worse, so that doesn’t bode well for The Exorcist films – David Gordon Green considering opting out of the remainder of this franchise isn’t all that much of a surprise. After all, Green tends to go with whatever catches his attention, resulting in one of the strangest career trajectories in all of movies. From his beginnings as an indie darling with films like George Washington (please watch this if you haven’t) and Undertow to directing stoner comedies like Pineapple Express and Your Highness to a serving as horror franchise resurrector (and whatever he was going for with Our Brand Is Crisis), Green has consistently defied expectations.

Under David Gordon Green, The Exorcist: Believer had a mixture of promise and skepticism leading to its release. But as it stands, it holds a 23% on Rotten Tomatoes, with our own Chris Bumbray giving it a 4/10 and ranking it just ahead of Exorcist II: The Heretic, which is certainly no compliment.

Do you want to see The Exorcist trilogy continue? Could it be better without David Goron Green behind the camera? Give us your take in the comments section below.

Originally published at https://www.joblo.com/david-gordon-green-may-not-direct-remaining-exorcist-films/

Is Nutrition the Answer to Long-COVID? A Clinical Trial Will Explore the Impacts of the Medical Food KetoCitra Together With a Low-Carbohydrate Diet

By
NT Editor
-
0
Is Nutrition the Answer to Long-COVID? A Clinical Trial Will Explore the Impacts of the Medical Food KetoCitra Together With a Low-Carbohydrate Diet

SANTA BARBARA, Calif., October 9, 2023 (Newswire.com) - Santa Barbara Nutrients, Inc. is pleased to announce that our medical food product, KetoCitra®, will be utilized in a pilot clinical trial for patients with long-COVID. The trial will be led by faculty members of the Keck School of Medicine of the University of Southern California (USC). They include Nuria Pastor-Soler, MD, PhD, who is an associate professor of medicine and nephrologist; Kenneth Hallows MD, PhD, who is a professor of medicine and nephrologist; and Adupa Purush Rao, MD, who is a clinical associate professor of medicine, pulmonologist, and critical care medicine specialist with Keck Medicine of USC's COVID Recovery Clinic. (To learn more about the clinic or to schedule a visit, please visit this webpage: https://www.keckmedicine.org/covid-recovery-clinic/).  

According to federal statistics, over 4 million Americans suffer from long-term, often disabling symptoms known as long-COVID. Currently, there are no established treatments for this condition, and the mechanisms that cause long-COVID are not fully understood. The hyper-inflammatory responses seen in acute COVID-19 are also a feature of long-COVID, which often lead to disabling, highly varied symptoms. Common symptoms include fatigue, brain fog, muscle and chest pains, migraines, shortness of breath, anosmia, muscle weakness, cognitive dysfunction, and decreased kidney function. 

For this clinical study, investigators at USC will be implementing a protocol to evaluate the impacts of dietary interventions in long-COVID patients. The dietary interventions are aimed at lowering blood glucose levels and raising blood ketone (Beta-hydroxybutyrate, BHB) levels. The diet plan will recommend a low-carbohydrate diet supported by the medical food KetoCitra®, which will deliver exogenous BHB to raise blood ketone levels without adhering to a strict ketogenic diet. 

The study will follow up to 50 long-COVID patients who will either undergo a 30-day dietary intervention or continue their standard care plan. Study endpoints will investigate the feasibility, tolerability, and safety of the diet in individuals with long-COVID, changes in metabolic health, kidney function, and inflammatory markers, and changes in long-COVID signs and symptoms between the two groups. To learn more about the clinical trial, visit: https://www.clinicaltrials.gov/study/NCT05836402

The study is funded by a generous gift of the Amy P. Goldman Foundation to USC. 

KetoCitra® was developed by Santa Barbara Nutrients as a medical food that is currently marketed for the daily nutritional management of individuals with Chronic Kidney Disease (CKD) and Polycystic Kidney Disease (PKD) and is intended to be used under medical supervision. It is covered by granted patents (US Patent No. 11,013,705 & Mexican Patent No. 395975) and additional foreign patents pending. For more information about KetoCitra®, visit: https://santabarbaranutrients.com/ketocitra

# # # 

About Santa Barbara Nutrients, Inc. 
Santa Barbara Nutrients, Inc. is a public benefit corporation headquartered in Santa Barbara, California. The company is committed to scientific and clinical research to develop science-backed products that support human health and address significant unmet medical needs. For more information, please visit https://santabarbaranutrients.com or contact [email protected] 

Contact Information:
Gregg Bretz
CEO, Santa Barbara Nutrients
[email protected]
+36309418935

Mollee Rucker
Business Development, Santa Barbara Nutrients
[email protected]

Emily Muensterman
Clinical Research Manager, Santa Barbara Nutrients
[email protected]
636-795-3093


Original Source: Is Nutrition the Answer to Long-COVID? A Clinical Trial Will Explore the Impacts of the Medical Food KetoCitra Together With a Low-Carbohydrate Diet

Introducing the Future of Histology: Groundbreaking 3D Viewer Unveiled to Reveal Tumor Spatial Characteristics

By
NT Editor
-
0
Introducing the Future of Histology: Groundbreaking 3D Viewer Unveiled to Reveal Tumor Spatial Characteristics

CHICAGO, October 9, 2023 (Newswire.com) - Wision A.I., a cutting-edge software medical device startup, is proud to announce the launch of our latest innovation at the annual meeting of College of American Pathologists 2023: PathoCruz 3D, an automated histological 3D reconstruction tool. Designed to elevate the art of tumor histopathological assessment, this groundbreaking device promises to reveal the spatial characteristics of tumors.

Histopathology has long relied on two-dimensional (2D) representations of tissue samples to diagnose and understand diseases, particularly cancer. However, with the PathoCruz 3D Viewer, Wision A.I. is ushering in a new era of diagnostic precision. This innovative device utilizes advanced imaging technology and artificial intelligence to generate three-dimensional renderings of tissue samples with a granularity of 500um3, providing a comprehensive and spatially accurate view of tumors and surrounding tissues.

The key benefits of PathoCruz 3D include the following:

1. Spatial Accuracy for Enhanced Diagnostics: By synchronizing maps of cancerous regions across adjacent slides from a tumor, the software provides a unique perspective on factors such as size, shape, invasion depth, volume, and other spatial metrics. This breakthrough significantly improves diagnostic precision, paving the way for the development of personalized treatment plans for patients.

2. Automated Post-Procedure Assessments: Many procedures, especially those involving serial sectioning and meticulous assessment of surgical resection margins, such as endoscopic submucosal dissection (ESD), demand careful evaluation of remaining risks. This software offers the advantage of automating post-procedure pathological assessments, thereby saving valuable time.

3. Educational Value: Medical institutions can use this technology to enhance education and training in the fields of histology and pathology, ensuring the next generation of professionals is equipped with the latest tools and knowledge.

4. Research Advancements: Researchers and scientists can accelerate their studies by gaining deeper insight into the spatial characteristics of tumors, potentially leading to breakthroughs in cancer treatment.

Dr. Sophie Xiao, Chief Scientist at Wision A.I., emphasizes the importance of this groundbreaking innovation, stating, "PathoCruz 3D relies on precise cancer localization AI algorithms operating at the 2D whole-slide imaging level. Recognizing histological features across various cancers has always presented technical challenges; however, investment is justified. Accurate 2D localization and 3D reconstruction enable healthcare professionals to perceive tumors in their complete spatial context, enabling more precise and effective treatments. We are confident that this technology will profoundly impact patient care and advance medical research."

The PathoCruz 3D is set to bring new understanding to professionals about tumor characteristics. Its potential applications extend beyond oncology to various fields, making it a versatile tool for the pathology community.

PathoCruz 3D is now for research and educational use only in the United States. For more information about PathoCruz 3D and its capabilities, please contact [email protected].

About Wision A.I.

Wision A.I. has extensive expertise in mathematics and algorithm development. The company integrates medical knowledge into flexible and scalable models that leverage cutting-edge deep neural networks and general-purpose computing to achieve stable detection efficacy in diagnostic imaging.

Contact Information:
Min Yang
[email protected]
+8613910308383


Original Source: Introducing the Future of Histology: Groundbreaking 3D Viewer Unveiled to Reveal Tumor Spatial Characteristics

Borat director disgusted by overblown budgets

By
NT Editor
-
0
Borat director disgusted by overblown budgets

Larry Charles, who turned the $18 million Borat into a $260+ million success, thinks studios should be ashamed of excessive budgets.

With Larry Charles’ latest movie, Dicks: The Musical now out, the director has laid out just why he is keeping his budgets low. And no, it has nothing to do with studios refusing to pony up for dicks or musicals.

Appearing on Marc Maron’s WTF podcast last week, Larry Charles expressed his disdain for studios giving certain movies outlandish budgets. “Politically for me, ethically for me, I find it offensive when movies cost $250 million and the world is in the state that it’s in. So I’m also looking to make a statement in the way these things are made.” Larry Charles further defended his take by saying, “We have such a media monopoly system here that that in itself is kind of an authoritarian Big Brother sort of thing that we — they’ve figured out over the years, they don’t have to make you, they don’t have to scare you, they have to seduce you. So we’re all seduced by great TV shows and great movies, and we’re distracted by those things, and we’re then indulging in that same capitalist system and there’s no way it’s going to change as long as we do that… I struggle with that.” For what it’s worth, five movies released so far this year have had budgets of at least $250 million and we’d love to see the look on Larry Charles’ face when he hears that Fast X was pegged at $340 million — that’s almost 20 Borats!

Larry Charles has made his post-Seinfeld/Curb Your Enthusiasm career out of stories and styles that typically don’t require large budgets, with his highest being The Dictator‘s $65 million. (His other Sacha Baron Cohen collaborations, Brüno and Borat, cost $42 million and $18 million, respectively; he did not direct Borat’s sequel) Still, even with modest budgets, Larry Charles knows the studio is always keeping the box office in mind. “The way I can make a radical work is by saying that I could do it for a little money, and the way [producers] say yes to it is they think, ‘Oh, that radical little work that’s not going to cost any money is going to make money.’ Absolutely. That is the system.”

Outside of Dicks: The Musical, Larry Charles may helm a sequel to the Bill Maher-led Religulous.

Do you agree or disagree with Larry Charles’ statements about overblown budgets? Give us your take in the comments section below.

Originally published at https://www.joblo.com/borat-director-disgusted-by-overblown-budgets/

Vitakraft (R) Announces ‘The Trick & Treat Halloween Costume Contest’ for Pets

By
NT Editor
-
0
Vitakraft (R) Announces ‘The Trick & Treat Halloween Costume Contest’ for Pets

BOWLING GREEN, Ohio, October 9, 2023 (Newswire.com) - This Halloween, the renowned international pet food brand Vitakraft® is inviting pets and their parents to join the “Trick & Treat Halloween Costume Contest.” In a move to encompass the diverse array of pets cherished in homes everywhere, the contest welcomes cats, dogs, and small animals, such as rabbits, guinea pigs, and hamsters, as well as birds, such as parrots, canaries, love birds, and many more. 

Participation has been made effortless. Pet parents need only to post a photo or video of their costumed pet on social media and tag Vitakraft to enter. It’s an opportunity for all pets to shine.

Get inspired with this video entry example: a Halloween adventure with the feline duo Kona & Kai! 

Meet these requirements by October 27, and you could be one of the 20 lucky winners to receive a basket brimming with $100 worth of treats!

In the mix of this delightful contest, safety and enjoyment are prioritized. As part of the contest’s interactive nature, Molly DeVoss, a Certified Feline Training & Behavior Specialist, will share tips to ensure pets are safe and comfortable. For example, for cats, "During Halloween, there are frequent door openings as trick-or-treaters come and go. Make sure your cat doesn’t slip out by accident. If you don't confine your cat to a safe room, consider using a baby gate at the front door." 

The “Trick & Treat Halloween Costume Contest” underscores Vitakraft’s commitment to all pets in the family. “Every pet, from playful puppies and kittens to chirpy birds and cuddly small animals, is part of the Vitakraft family. This contest is a delightful testament to the variety of pets we cater to with our extensive product range,” Miquel Gonzalez, Chief Marketing Officer at Vitakraft, explained.

To coincide with the Halloween festivity, Vitakraft is also unveiling the "Monster Value Pack Lick 'n’ Lap Snack," a delightful addition for the feline members of the family, just in time for Halloween.

To learn more about Vitakraft products, visit www.vitakraft.us.

Contact Information:
Hayden Ari
Marketing Manager
[email protected]
9734054600


Original Source: Vitakraft (R) Announces 'The Trick & Treat Halloween Costume Contest’ for Pets
1...202203204...580Page 203 of 580
© Newsmag WordPress Theme by TagDiv